|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 167.40 EUR | -0.83% |
|
-1.93% | +40.67% |
| 09/07 | Wall Street Ignores the Sirens |  |
| 09/07 | Ipsen Reports Positive Topline Phase III Results for Dysport in Both Episodic and Chronic Migraine | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSEN | Other Pharmaceuticals | -0.83% | -1.93% | +40.67% | +54.71% | +91.18% | 15.84B |  | | |
- Stock Market
- Stocks
- IPN Stock
- Charts Ipsen
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
